CN1228319A - Chinese patent drug for curing hypertension - Google Patents
Chinese patent drug for curing hypertension Download PDFInfo
- Publication number
- CN1228319A CN1228319A CN 98111586 CN98111586A CN1228319A CN 1228319 A CN1228319 A CN 1228319A CN 98111586 CN98111586 CN 98111586 CN 98111586 A CN98111586 A CN 98111586A CN 1228319 A CN1228319 A CN 1228319A
- Authority
- CN
- China
- Prior art keywords
- medicine
- chinese patent
- weight
- blood
- patent medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The Chinese patent medicine for curing hypertension contains (wt%) 25-35% of ligusticum root, 15-20% of red sage root, 20-25% of Chinese angelica root, 10-15% of carthamus flower and 15-25% of dried/fresh rehmannia. Its preparation method includes the following steps: cleaning all medicinal materials, removing impurities, drying in the shade, pulverizing, screening, mixing them with pitted date, pounding into paste and making the medicinal paste into medicinal pill. Said medicine can effectively control and cure hypertension, its medicine effect time is long, and side effect is small.
Description
The invention belongs to Chinese patent medicine, especially for the Chinese patent medicine of treatment high blood pressure disease.
At present, on the market both domestic and external, the kind of the blood pressure lowering medicine of reduction high blood pressure disease patient's pressure value (hereinafter to be referred as blood pressure lowering) is more, press pyridine as chlorine, methyldopa, the pyridine of long pressure, nitre benzene is than medicines such as pyridine and FUFANG JIANGYA PIAN, and main purpose is to reduce the tensity of blood vessel, blood vessel dilating, though hypotensive effect is arranged, but can only disease controlling, only be blood pressure lowering for blood pressure lowering, in case drug withdrawal, patient's blood pressure gos up again, can not fundamentally cure, bigger to the dependency of medicine, effective drug duration is short, generally at 6-7 hour, the longlyest also be no more than 10 hours, and most antihypertensive drugs all has certain side effect, the patient should not take for a long time.
The object of the present invention is to provide a kind of state of an illness that can effectively control the high blood pressure disease patient, effective drug duration is long, the Chinese patent medicine of the treatment high blood pressure disease that side effect is little.
Solution of the present invention is for containing the Rhizoma Chuanxiong of 25-30 (weight) %, the Radix Salviae Miltiorrhizae of 15-20 (weight) %, the Radix Angelicae Sinensis of 20-25 (weight) %, the Flos Carthami of 10-15 (weight) %, the Radix Rehmanniae of 15-25 (weight) %, with above-mentioned respectively distinguish the flavor of medicine through conventional Chinese patent medicine preparation method clean, the roguing thing, dry in the shade, pulverize, sieve after, the enuleation date that adding can make the above-mentioned medicine of respectively distinguishing the flavor of be sticked together, smash into the mud shape, make the Chinese patent medicine ball.
Pharmacological effect of the present invention is as follows: the damage that has its source in of hypertension, wound, imbalance of YIN and YANG, QI and blood loss, and in solution of the present invention, Rhizoma Chuanxiong energy blood-activating and qi-promoting, wind-expelling pain-stopping; Radix Salviae Miltiorrhizae energy blood circulation promoting and blood stasis dispelling, removing heat from blood, nourishing blood to tranquillize the mind; Last two flavor medicines share, have invigorate blood circulation, pain relieving, circulation of qi promoting, broken stagnant merit.Radix Angelicae Sinensis can be enriched blood, be invigorated blood circulation; Flos Carthami energy promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing; This two flavors medicine share, have enrich blood, nourish blood, the merit of stasis-dispelling and pain-killing.The yin nourishing of Radix Rehmanniae energy, removing heat from blood; Five kinds of Chinese medicine of the present invention share can regulate negative and positive effectively, recovers blood vessel elasticity, repairs the damage of blood vessel wall, blood-supplementing blood-nourishing, the analgesic therapy of calming the nerves.
After using the present invention, can effectively control and treat high blood pressure disease, effective drug duration is long, and side effect is little.
Provide one embodiment of the present of invention below.
Now embodiment is explained in detail: with Rhizoma Chuanxiong 50 gram, Radix Salviae Miltiorrhizae 35 grams, Radix Angelicae Sinensis 40 grams, Flos Carthami 20 grams, the Radix Rehmanniae 35 grams through conventional Chinese patent medicine preparation method clean, the roguing thing, dry in the shade, pulverize after, cross 120 mesh sieves, make medicated powder, again 20 gram enuleation dates are put into above-mentioned medicated powder, and mix, smash into the mud shape, make every the 10 Chinese patent medicine ball about gram.
Instructions of taking and dose: oral on an empty stomach, eliminating cold for resuscitation water send down, and three times on the one, one time one ball, 15 days is a course of treatment.
The clinical trial situation: the hypertensive diagnostic criteria of using with The World Health Organization's suggestion is foundation: systolic pressure is equal to or greater than 160 millimetress of mercury, and diastolic pressure is equal to or greater than 95 millimetres of mercury persons and is hypertension; Normal person's systolic pressure is 140 millimetress of mercury, and diastolic pressure is 90 millimetress of mercury.
Accept hypertensive patient 395 people altogether for medical treatment, the oldest person 75 years old, reckling 40 years old.Patient's systolic pressure is up to 210 millimetress of mercury, and the diastolic pressure soprano is 160 millimetress of mercury.
Medicine time: course of treatment of the shortest person, elder is three courses of treatment.Wherein, 105 of the patients who takes medicine a course of treatment, 175 of the patients who takes medicine two courses of treatment, 115 of the patients who takes medicine three courses of treatment.
The curative effect classification:
Cure--after taking medicine, patient's systolic pressure, diastolic pressure are reduced to normally, and drug withdrawal not rising of blood pressure person after three months;
Effectively--after taking medicine, patient's systolic pressure, diastolic pressure are reduced to normally, but blood pressure deviant again in three months after the drug withdrawal;
Produce effects--after taking medicine, patient's systolic pressure, diastolic pressure are reduced to normally, but blood pressure rise person again in the week after the drug withdrawal;
Invalid--not descender of back blood pressure takes medicine.
Therapeutic outcome:
Cure 296 people, account for 75% of patient's sum;
Effective 51 people account for 13% of patient's sum;
Produce effects 31 people account for 8% of patient's sum;
Invalid 17 people account for 4% of patient's sum;
Total effective rate is 96%.
Wherein:
In 105 patients of the course of treatment of taking medicine, cure 56 people, account for 53%; Effective 32 people account for 30%; Produce effects 7 people account for 7%; Invalid 10 people account for 10%;
In 175 patients of two courses of treatment of taking medicine, cure 140 people, account for 80%; Effective 10 people account for 6%; Produce effects 20 people account for 11%; Invalid 5 people account for 3%;
In 115 patients of three courses of treatment of taking medicine, cure 100 people, account for 87%; Effective 9 people account for 8%; Produce effects 4 people account for 3%; Invalid 2 people account for 2%.
Claims (1)
- A kind of Chinese patent medicine for the treatment of high blood pressure disease, it is characterized in that containing the Rhizoma Chuanxiong of 25-30 (weight) %, the Radix Salviae Miltiorrhizae of 15-20 (weight) %, the Radix Angelicae Sinensis of 20-25 (weight) %, the Flos Carthami of 10-15 (weight) %, the Radix Rehmanniae of 15-25 (weight) %, with above-mentioned respectively distinguish the flavor of medicine through conventional Chinese patent medicine preparation method clean, the roguing thing, dry in the shade, pulverize, sieve after, the enuleation date that adding can make the above-mentioned medicine of respectively distinguishing the flavor of be sticked together, smash into the mud shape, make the Chinese patent medicine ball.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98111586A CN1061555C (en) | 1998-11-19 | 1998-11-19 | Chinese patent drug for curing hypertension |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN98111586A CN1061555C (en) | 1998-11-19 | 1998-11-19 | Chinese patent drug for curing hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1228319A true CN1228319A (en) | 1999-09-15 |
| CN1061555C CN1061555C (en) | 2001-02-07 |
Family
ID=5221558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN98111586A Expired - Fee Related CN1061555C (en) | 1998-11-19 | 1998-11-19 | Chinese patent drug for curing hypertension |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1061555C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931260B (en) * | 2006-09-23 | 2010-09-08 | 孟平安 | Hyperlipemia treating oral liquid |
| CN104367696A (en) * | 2013-08-16 | 2015-02-25 | 黄雄强 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| CN109771590A (en) * | 2019-03-05 | 2019-05-21 | 王进军 | A kind of oral medicinal herb pulvis of blood pressure lowering |
| CN112451625A (en) * | 2020-12-24 | 2021-03-09 | 马玉印 | Traditional Chinese medicine watered pill for preventing and treating three highs and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1025477C (en) * | 1993-01-09 | 1994-07-20 | 李继田 | Medicine for cure hypertension sickness |
-
1998
- 1998-11-19 CN CN98111586A patent/CN1061555C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1931260B (en) * | 2006-09-23 | 2010-09-08 | 孟平安 | Hyperlipemia treating oral liquid |
| CN104367696A (en) * | 2013-08-16 | 2015-02-25 | 黄雄强 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| CN109771590A (en) * | 2019-03-05 | 2019-05-21 | 王进军 | A kind of oral medicinal herb pulvis of blood pressure lowering |
| CN112451625A (en) * | 2020-12-24 | 2021-03-09 | 马玉印 | Traditional Chinese medicine watered pill for preventing and treating three highs and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1061555C (en) | 2001-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104147284B (en) | Chinese herbal preparation for treating epilepsy and preparation method thereof | |
| CN101972373A (en) | Chinese medicinal preparation for treating hypertension, hyperglycemia and hyperlipidemia | |
| CN1895620A (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN102670776B (en) | Traditional Chinese medicine composition for curing rheumatism | |
| CN102698092A (en) | Traditional Chinese medicine composition for treating liver-Yang hyperactivity-type hypertension | |
| CN100396321C (en) | Preparation of Chinese traditional medicine for treating hyperosteogeny | |
| CN1061555C (en) | Chinese patent drug for curing hypertension | |
| CN106214986A (en) | A kind of Chinese medicine decoction treating cardiovascular and cerebrovascular disease | |
| CN1256926A (en) | Pill for treating hemiplegia | |
| CN1169546C (en) | Chinese medicine for treating hypotension | |
| CN1087619C (en) | Medicines for treating osteoporosis and their preparing process | |
| CN101195002B (en) | Chinese medicine emplastrum for releasing ache and health care | |
| CN101041021A (en) | Chinese medicines composition took orally for treating vrain apoplexy | |
| CN1098299A (en) | The sweet cool Kouchuang powder for curing aphthosis and the compound method thereof that are used for recurrent aphtha and all kinds of aphthas | |
| CN1086586C (en) | Medicine for treating cardiac and cerebral vascular diseases and its preparation | |
| CN103212039A (en) | Traditional Chinese medicine composition for treating infantile cough caused by qi deficiency | |
| CN1075726C (en) | Oral liquid for treatment of heart disease and its prepn. method | |
| CN113713068B (en) | Foot bath powder capable of tonifying spleen, eliminating dampness, promoting blood circulation and soothing nerves | |
| CN100496576C (en) | Medicine for treating cardiovascular disease | |
| CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
| CN1115160C (en) | Orally-applied medicine for treating hyperosteogeny | |
| CN1404847A (en) | Medicine for treating sequel resulted from cardio-cerebral blood-vessel diseases | |
| CN1184975C (en) | Medicine for treating obsessional neurosis via head acupoint osmosis | |
| CN1183918C (en) | Medicine for curing protrution of intervetebral disc and its preparing method | |
| CN1225838A (en) | Medicinal liquor for treating hypertension |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010207 Termination date: 20091221 |